Abstract
Calcineurin (CN) is a heterodimer of a catalytic subunit, calcineurin A (CNA), and a regulatory subunit (CNB). Here, we find that the mechanism by which CNB regulates CNA depends on the substrate involved. The regulation mechanism involving tau and its truncation segments is distinct from that involving RII peptide, and the efficiencies of CNA to dephosphorylate tau are constant regardless of whether CNB was present or not. The findings shed some light on the role of CNB in controlling phosphorylation of tau in vivo and the pathogenesis of tauopathies such as Alzheimers Disease.
Keywords: Calcineurin A subunit, calcineurin B subunit, tau, RII peptide, dephosphorylation, Alzheimer's Disease
Protein & Peptide Letters
Title: Different Regulation Modes of Calcineurin Regulatory Subunit on Its Catalytic Subunit with RII Peptide and Tau as Substrates
Volume: 16 Issue: 2
Author(s): Da-yu Yu, Nan Qiao, Ping Liu and Qun Wei
Affiliation:
Keywords: Calcineurin A subunit, calcineurin B subunit, tau, RII peptide, dephosphorylation, Alzheimer's Disease
Abstract: Calcineurin (CN) is a heterodimer of a catalytic subunit, calcineurin A (CNA), and a regulatory subunit (CNB). Here, we find that the mechanism by which CNB regulates CNA depends on the substrate involved. The regulation mechanism involving tau and its truncation segments is distinct from that involving RII peptide, and the efficiencies of CNA to dephosphorylate tau are constant regardless of whether CNB was present or not. The findings shed some light on the role of CNB in controlling phosphorylation of tau in vivo and the pathogenesis of tauopathies such as Alzheimers Disease.
Export Options
About this article
Cite this article as:
Yu Da-yu, Qiao Nan, Liu Ping and Wei Qun, Different Regulation Modes of Calcineurin Regulatory Subunit on Its Catalytic Subunit with RII Peptide and Tau as Substrates, Protein & Peptide Letters 2009; 16 (2) . https://dx.doi.org/10.2174/092986609787316243
DOI https://dx.doi.org/10.2174/092986609787316243 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ginkgo Biloba Extract (EGb 761) in Alzheimers Disease: Is there Any Evidence?
Current Alzheimer Research Old Age Before Cognitive Impairment
Current Alzheimer Research Comparing the Effects of Drug Therapy, Perceptual Motor Training, and Both Combined on the Motor Skills of School-Aged Attention Deficit Hyperactivity Disorder Children
CNS & Neurological Disorders - Drug Targets Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Current Drug Targets Cerebral Microbleeds Do Not Predict Hemorrhagic Transformation in Acute Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease
Current Neurovascular Research Adenosine and Stroke: Maximizing the Therapeutic Potential of Adenosine as a Prophylactic and Acute Neuroprotectant
Current Neuropharmacology Synthesis and Biological Evaluation of New imidazo[1,2-a]pyridine Derivatives as Selective COX-2 Inhibitors
Letters in Drug Design & Discovery Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease
Current Pharmaceutical Design The Correlations between Postmortem Brain Pathologies and Cognitive Dysfunction in Aging and Alzheimer's Disease
Current Alzheimer Research Adipose-Derived Stromal/Stem Cells (ASC) in Regenerative Medicine: Pharmaceutical Applications
Current Pharmaceutical Design Substance-Related and Addictive Disorders as a Risk Factor of Suicide and Homicide among Patients with ADHD: A Mini Review
Current Drug Abuse Reviews Kv7 Channels: Function, Pharmacology and Channel Modulators
Current Topics in Medicinal Chemistry Overdoses of Acetaminophen Disrupt the Thyroid-Liver Axis in Neonatal Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecule of the Month
Current Topics in Medicinal Chemistry Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review
Current Neuropharmacology The Potential of Embryonic Stem Cells Combined with -omics Technologies as Model Systems for Toxicology
Current Medicinal Chemistry A Pilot Study on Prostate Cancer Risk and Pro-Inflammatory Genotypes: Pathophysiology and Therapeutic Implications
Current Pharmaceutical Design Transforming Growth Factor-Beta: A Potential New Agent for Pleurodesis
Drug Design Reviews - Online (Discontinued) Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)
Current Pharmaceutical Design Acknowledgements to Reviewers:
Current Alzheimer Research